Pfizer sponsored an LGBT event for fifth-grade public school students in Chicago Public Schools

Natural News

<p>The claim made in the content is that the Centers for Disease Control and Prevention (CDC) and ViiV Healthcare, a pharmaceutical firm with links to Pfizer, sponsored an LGBT event for fifth-grade public school students in Chicago Public Schools (CPS).</p>
<p>After examining the sources provided and conducting further research, we found that ViiV Healthcare did indeed sponsor the Galaxy Summit, an annual event organized by the Children's First Fund, the non-profit arm of CPS.</p>
<p>The event aimed to create an affirming space for students to learn about and celebrate the diversity of gender, sexuality, and love in their communities.ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (GSK) and Pfizer.</p>
<p>Shionogi joined as a shareholder in October 2012. Therefore, the claim about ViiV Healthcare's connection to Pfizer is true.</p>
<p>However, there is no evidence supporting the claim that the CDC sponsored the Galaxy Summit. The source of the claim, an article from LifeSiteNews, does not provide any proof of CDC's involvement in the event.In conclusion, the claim that ViiV Healthcare, a company with ties to Pfizer, sponsored an LGBT event for CPS students is true.</p>
<p>However, the claim that the CDC was involved in sponsoring the event is unfounded and lacks evidence.</p>
<p>Sources:</p>
<p>1. LifeSiteNews:</p>
<p>2. ViiV Healthcare:</p>
<p>3. Children's First Fund:</p>
<p>4. Chicago Public Schools:</p>

Fact-checking the claim: CDC and Pfizer affiliate sponsor pro-LGBT public school event for fifth-graders

<h2>Introduction</h2>
<p>The recent approval of the ACAM2000 vaccine for monkeypox by the Food and Drug Administration (FDA) has sparked controversy due to its acknowledged risks, particularly cardiac inflammation. This article aims to review the claim that the FDA approved the vaccine despite knowing its dangers.</p>
<h2>Background</h2>
<p>The ACAM2000 vaccine, developed by Emergent BioSolutions, was initially approved for smallpox in 2007. On August 29, 2024, the FDA expanded its approval to include individuals at high risk for monkeypox, such as members of the LGBT community.</p>
<h2>Claim Analysis</h2>
<p>The claim suggests that the FDA approved the ACAM2000 vaccine despite knowing its risks. The FDA's medication guide for ACAM2000 lists numerous side effects, including the potential spread of the live vaccinia virus to close contacts and serious complications such as myopericarditis (heart lining and/or muscle inflammation).</p>
<p>According to Karl Jablonowski, a senior research scientist at Children's Health Defense, the risk of cardiac inflammation is significant, with estimates ranging from one in 2,000 to one in 175 vaccinations. Dr. Meryl Nass, an internist and biological warfare expert, also highlighted the CDC's acknowledgment of this risk during a June 2022 meeting.</p>
<p>However, it is crucial to understand the FDA's approval process. The agency evaluates the benefits and risks of a vaccine, especially in the context of public health emergencies. The approval of ACAM2000 for monkeypox was likely based on the assessment that the benefits outweigh the risks for high-risk individuals.</p>
<h2>Scientific Evidence</h2>
<p>The risk of myopericarditis associated with ACAM2000 is well-documented. A study published in the <a href="https://academic.oup.com/aje/article-abstract/160/7/642/136637?redirectedFrom=PDF#google_vignette">New England Journal of Medicine</a> &nbsp;reported cases of myopericarditis following smallpox vaccination, highlighting the need for careful monitoring and risk assessment.</p>
<p>The FDA's approval process involves rigorous evaluation of clinical data and consideration of public health needs. While the risks are acknowledged, the decision to approve the vaccine reflects a balance between these risks and the potential benefits in preventing monkeypox.</p>
<h2>Conclusion</h2>
<p>The claim that the FDA approved the ACAM2000 vaccine for monkeypox despite acknowledging its dangerous side effects is partially true. While the vaccine has known risks, the FDA's approval process considers the benefits versus the risks in the context of public health emergencies. It is essential for individuals to be informed about the potential side effects and for healthcare providers to monitor vaccinated individuals closely.</p>

Claim Review: FDA Approves Monkeypox Vaccine Despite Known Risks

<h2>Introduction</h2>
<p>The claim that the Canadian government contract with Pfizer acknowledged the unknown long-term efficacy and safety of COVID-19 vaccines has been circulating widely. This article aims to review this claim, providing a thorough analysis and context based on reliable scientific sources.</p>
<h2>The Claim</h2>
<p>The claim states that the contract between the Canadian government and Pfizer, dated October 26, 2020, includes a section acknowledging that the long-term effects, efficacy, and adverse effects of the vaccine were not known at the time of signing. This information was reported by The Expose and The Canadian Independent.</p>
<h2>Analysis</h2>
<p>The contract indeed contains a section (5.5) under 'Purchaser Acknowledgement' that states: 'Purchaser further acknowledges that the long-term effects and efficacy of the Vaccine are not currently known and that there may be adverse effects of the Vaccine that are not currently known.' This acknowledgment is standard in contracts for new medical products, reflecting the ongoing nature of scientific research and the need for continuous monitoring.</p>
<p>It is important to note that the acknowledgment of unknown long-term effects does not imply that the vaccines are unsafe. Vaccines undergo rigorous testing and approval processes by regulatory bodies such as Health Canada and the U.S. Food and Drug Administration (FDA). These processes ensure that vaccines meet high safety and efficacy standards before they are administered to the public.</p>
<p>Furthermore, ongoing monitoring and research are essential for understanding the long-term effects of any new medical intervention. This is a standard practice in the medical field and is not unique to COVID-19 vaccines.</p>
<h2>Scientific Evidence</h2>
<p>Several peer-reviewed studies and reports from reliable scientific sources support the safety and efficacy of COVID-19 vaccines. For example, a study published in <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2101765">The New England Journal of Medicine</a> found that the Pfizer-BioNTech COVID-19 vaccine was highly effective in preventing symptomatic COVID-19 infections. Another study published in <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00947-8/fulltext">The Lancet</a> reported similar findings for the Moderna vaccine.</p>
<p>These studies, along with ongoing surveillance by health authorities, provide evidence that COVID-19 vaccines are safe and effective in the short term. Long-term data is being continuously collected and analyzed to ensure the safety and efficacy of these vaccines over time.</p>
<h2>Conclusion</h2>
<p>The claim that the Canadian government contract with Pfizer acknowledged the unknown long-term efficacy and safety of COVID-19 vaccines is accurate. However, this acknowledgment is a standard practice in contracts for new medical products and does not imply that the vaccines are unsafe. Ongoing research and monitoring are essential for understanding the long-term effects of any new medical intervention. The available scientific evidence supports the safety and efficacy of COVID-19 vaccines in the short term, and long-term data is being continuously collected and analyzed.</p>

Claim Review: Canadian Government Contract with Pfizer on COVID-19 Vaccine Safety

<p>An official report by a Slovak government commission investigating the COVID-19 pandemic recommended mRNA vaccines be banned after determining they are ‘dangerous.’ This claim has gained attention, especially as it was followed by a similar call from the town council of Port Hedland in Western Australia. However, a thorough examination of the available scientific evidence does not support this claim.</p>
<h3>Understanding mRNA Vaccines</h3>
<p>mRNA vaccines, such as those developed by Pfizer-BioNTech and Moderna, work by instructing cells to produce a harmless piece of the ‘spike protein’ found on the surface of the SARS-CoV-2 virus. This triggers an immune response, preparing the body to fight the virus if exposed in the future. This technology has been studied for decades and has shown promising results in various applications, including cancer treatments and other infectious diseases.</p>
<h3>Safety and Efficacy of mRNA Vaccines</h3>
<p>The safety and efficacy of mRNA vaccines have been extensively studied and confirmed by numerous peer-reviewed studies and health organizations. For example, a study published in <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2034577">The New England Journal of Medicine</a> found that the Pfizer-BioNTech vaccine was 95% effective in preventing COVID-19. Similarly, a study published in <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2035389">The New England Journal of Medicine</a> found that the Moderna vaccine was 94.1% effective.</p>
<p>Regarding safety, a study published in <a href="https://www.cdc.gov/mmwr/volumes/70/wr/mm7002e3.htm">Morbidity and Mortality Weekly Report (MMWR)</a> by the Centers for Disease Control and Prevention (CDC) found that serious adverse events after mRNA vaccination were rare. The most common side effects were mild to moderate and included pain at the injection site, fatigue, headache, and muscle pain.</p>
<h3>Addressing Concerns</h3>
<p>The Slovak government commission's report raises concerns about the safety of mRNA vaccines, but these concerns are not supported by the broader scientific community. The World Health Organization (WHO), the European Medicines Agency (EMA), and the U.S. Food and Drug Administration (FDA) have all reviewed the data on mRNA vaccines and concluded that they are safe and effective.</p>
<p>It is important to note that any medical intervention, including vaccines, can have side effects. However, the benefits of mRNA vaccines in preventing severe COVID-19, hospitalization, and death far outweigh the risks. The rare cases of serious adverse events, such as myocarditis and anaphylaxis, have been closely monitored and studied, and the overall risk remains very low.</p>
<h3>Conclusion</h3>
<p>The claim that mRNA vaccines are dangerous and should be banned is not supported by scientific evidence. The safety and efficacy of mRNA vaccines have been extensively studied and confirmed by numerous peer-reviewed studies and health organizations. While it is important to continue monitoring the safety of these vaccines, the available data strongly support their use in preventing COVID-19.</p>
<p>For high school students and the general public, it is crucial to rely on credible sources of information and to critically evaluate claims made in the media. Misinformation can spread quickly and have serious consequences for public health. Always seek information from reliable scientific sources and consult with healthcare professionals for medical advice.</p>

Claim Review: Slovak Government Report Calls for Ban of ‘Dangerous’ mRNA Vaccines

If you want to replace an existing title on a portal and you want the replaced title to be visible to you and your followers.

Move the mouse over the title and make a right click.

Select Remedia -> Alternate Title from the menu

In the pop-up window, enter a new title that you like.

The blue icon copies the existing title into the input field, so you don't have to type everything...

By pressing Submit, the title will be replaced, which will be visible to you and others who visit the pages.

(There is a possibility that you will have to reload the page for the changes to be visible)

You can contact one of the fact-checking organizations.

Claim rated as -> Choose from false to true

Add claimer -> Opens a pop-up window that allows you to search for existing people already registered in the system or to create a new profile of that person.

Claimed At -> Enter the link to the page where the claim was found. You can add more places and link more claim authors

Short description -> short content that is seen when sharing articles on social networks

Field for entering the content of the article.

After the article is published, it will be visible on the Remedia social network and to everyone who has the Remedia Chrome extension installed

And you can engage in debunking yourself.

CAUTION! Abusing the platform is not allowed, entering unverified, misleading or untrue content will result in the deletion of the entire account with all content

Canonical -> If you enter content that already exists somewhere (your property), you can enter a link and Remedia will try to enter the content in the provided fields.

Featured image -> Image that is displayed when you share an article on other social networks.

Write your title -> Enter the title of the article

The claim being reviewed -> Enter the claim here, but BEWARE! An assertion is not the entire statement someone has made, but something concise and unambiguous. Check the claim entry multiple times as each change will create a new claim in the system.

Claim made on -> date when someone published the claim.

After installing the Chrome extension, you can log in and use advanced functionalities. One of them is 'Dislike'.

By right-clicking on an article, the options provided by the Remedia extension are opened, by selecting Dislike, the article will become more transparent and less visible.

Your action will be visible to you and all people who follow you!

Alternate Title

1. Log in to the Remedia social network with a Google or Facebook account (link above right).

2. Install the Chrome extension (if you didn't)

4. Enter the email you used to open your Google or Facebook account. Submit.

5. After the input field appears, rewrite the code. Accept.

That's it! Now you can use the advanced functions of the Remedia Chrome extension.

Alternate Titles

Remedia's work so far:

Remedia, the best thing that happened to media!

On the Feed page, you can enter Status, Opinion and Claim Review

It is enough to enter the title, short description and content.

Below the fields for entering content, you will find fields for entering links. By entering page links in these fields, you 'show' the Chrome extension on which pages to display your content

Press Publish to publish your opinion. (It may be necessary to wait a moment while all links are generated)

Claim: "Pfizer sponsored an LGBT event for fifth-grade public school students in Chicago Public Schools" is Half True

Has beed claimed by:

Articles reviewing this claim:

Content you might like: